Luc Van Kaer Selected Research

Anti-Bacterial Agents (Antibiotics)

1/2017

Nanoparticle-Formulated Curcumin Prevents Posttherapeutic Disease Reactivation and Reinfection with Mycobacterium tuberculosis following Isoniazid Therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Luc Van Kaer Research Topics

Disease

24	Inflammation (Inflammations) 06/2023 - 04/2003
12	Tuberculosis (Tuberculoses) 01/2020 - 11/2011
12	Infections 11/2019 - 04/2002
11	Neoplasms (Cancer) 10/2023 - 03/2002
10	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2022 - 04/2002
7	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 05/2002
6	Leukemia 01/2017 - 11/2008
6	Atherosclerosis 04/2013 - 06/2004
5	Colitis 12/2022 - 01/2011
5	Multiple Sclerosis 01/2022 - 06/2004
5	Obesity 01/2022 - 05/2012
4	Sarcoidosis (Schaumann Disease) 02/2023 - 01/2018
4	Interstitial Lung Diseases (Interstitial Lung Disease) 02/2023 - 01/2018
4	Disease Progression 01/2021 - 06/2004
4	Insulin Resistance 01/2016 - 05/2012
4	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2011 - 06/2004
3	Fibrosis (Cirrhosis) 02/2023 - 01/2018
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 02/2023 - 01/2018
3	Granuloma 01/2023 - 01/2002
3	Sepsis (Septicemia) 03/2021 - 01/2015
3	Reinfection 01/2017 - 06/2014
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2011 - 06/2004
3	Myasthenia Gravis 06/2010 - 12/2005
2	Liver Diseases (Liver Disease) 05/2024 - 10/2004
2	Dysbiosis 02/2023 - 01/2023
2	Metabolic Diseases (Metabolic Disease) 01/2023 - 01/2023
2	Malaria 01/2019 - 03/2002
2	Communicable Diseases (Infectious Diseases) 01/2017 - 11/2016
2	Uveitis 12/2016 - 08/2003
2	Pulmonary Tuberculosis 11/2016 - 01/2009
2	Bacterial Infections (Bacterial Infection) 06/2015 - 09/2003
2	Virus Diseases (Viral Diseases) 02/2013 - 02/2011
2	Hepatitis 06/2008 - 10/2004
2	Lupus Nephritis 04/2005 - 08/2003
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2005 - 06/2004
2	Dermatitis 06/2004 - 10/2003
1	Breast Neoplasms (Breast Cancer) 10/2023
1	Triple Negative Breast Neoplasms 10/2023
1	Atopic Dermatitis (Atopic Eczema) 06/2023
1	Fatty Liver 01/2023
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2022

Drug/Important Bio-Agent (IBA)

21	CytokinesIBA 02/2023 - 05/2002
18	alpha-galactosylceramideIBA 02/2009 - 03/2002
15	AntigensIBA 01/2017 - 03/2002
13	GlycolipidsIBA 01/2022 - 01/2002
8	LipidsIBA 01/2023 - 12/2004
7	Interleukin-17 (Interleukin 17)IBA 02/2023 - 01/2011
7	Interleukin-10 (Interleukin 10)IBA 10/2019 - 01/2011
7	LigandsIBA 01/2018 - 05/2002
5	Proteins (Proteins, Gene)FDA Link 01/2023 - 06/2007
5	Interleukin-4 (Interleukin 4)IBA 11/2019 - 04/2005
5	VaccinesIBA 11/2016 - 03/2002
4	LipopolysaccharidesIBA 01/2022 - 11/2006
3	Phosphotransferases (Kinase)IBA 05/2024 - 01/2023
3	Bleomycin (Blenoxane)FDA LinkGeneric 02/2023 - 01/2018
3	Isoniazid (Ftivazide)FDA LinkGeneric 01/2020 - 10/2014
3	Apolipoproteins E (ApoE)IBA 04/2013 - 10/2004
3	ApolipoproteinsIBA 04/2013 - 10/2004
3	Histocompatibility Antigens Class IIBA 10/2011 - 03/2005
3	Cholinergic ReceptorsIBA 06/2010 - 12/2005
3	Concanavalin AIBA 06/2008 - 10/2004
2	Estrogens (Estrogen)FDA Link 02/2023 - 01/2023
2	Gonadal HormonesIBA 02/2023 - 01/2023
2	Hormones (Hormone)IBA 02/2023 - 01/2023
2	InterferonsIBA 01/2023 - 01/2011
2	Transcription Factors (Transcription Factor)IBA 01/2023 - 06/2008
2	Dextran SulfateIBA 12/2022 - 02/2014
2	Myelin-Oligodendrocyte GlycoproteinIBA 01/2022 - 01/2021
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2022 - 01/2021
2	Class III Phosphatidylinositol 3-KinasesIBA 01/2022 - 01/2021
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021 - 01/2013
2	CurcuminIBA 11/2019 - 01/2017
2	AntibodiesIBA 01/2017 - 10/2009
2	interstitial retinol-binding proteinIBA 12/2016 - 08/2003
2	Peptides (Polypeptides)IBA 12/2016 - 04/2002
2	Interleukin-12 (IL 12)IBA 06/2015 - 06/2008
2	Messenger RNA (mRNA)IBA 02/2013 - 12/2012
2	Monoclonal AntibodiesIBA 04/2011 - 11/2006
2	Galactosylceramides (Galactocerebrosides)IBA 02/2011 - 01/2002
2	Neutralizing AntibodiesIBA 01/2011 - 10/2004
2	Immunoglobulin G (IgG)IBA 01/2011 - 01/2008
2	AutoantigensIBA 01/2011 - 12/2005
2	thymus-leukemia antigensIBA 11/2010 - 11/2008
2	EpitopesIBA 01/2008 - 10/2004
2	pristane (pristan)IBA 04/2005 - 08/2003
2	HydrocarbonsIBA 04/2005 - 08/2003
1	Immune Checkpoint InhibitorsIBA 10/2023
1	ZymosanIBA 07/2023
1	Interleukin-7 (Interleukin 7)IBA 06/2023
1	Lymphoid Enhancer-Binding Factor 1IBA 01/2023
1	CollagenIBA 01/2023
1	Chimeric Antigen ReceptorsIBA 01/2023
1	Tyrosine (L-Tyrosine)FDA Link 01/2023
1	OligonucleotidesIBA 12/2022
1	Mitochondrial DNA (mtDNA)IBA 12/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	PlasticsIBA 01/2022

Therapy/Procedure

11	Therapeutics 10/2023 - 01/2005
10	Immunotherapy 10/2023 - 06/2004
2	Ovariectomy (Oophorectomy) 02/2023 - 01/2023